Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

CALCAGNO

Showing results (1011-1020 of 1,352) with videos related to

Pageof 136
Sort By:
Cancer|December 24, 1997
A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumorsG Mariani, A Lasku, A Pau, et al.
Infection|May 20, 2015
Ageing with HIV: a multidisciplinary reviewA Calcagno, S Nozza, C Muss, et al.
Gut|March 9, 2007
HLA related genetic risk for coeliac diseaseMathieu Bourgey, Giuseppe Calcagno, Nadia Tinto, et al.
Anticancer Research|July 15, 2009
MYC insertions in diffuse-type gastric adenocarcinomaDanielle Queiroz Calcagno, Adriana Costa Guimarães, Mariana Ferreira Leal, et al.
Therapeutic Drug Monitoring|March 13, 2012
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical settingMarco Siccardi, Antonio DʼAvolio, Sonia Rodriguez-Novoa, et al.
The Laryngoscope|July 5, 2019
Incidence of inadequate perforators and salvage options for the anterior lateral thigh free flapWilliam W Thomas, Haley E Calcagno, James Azzi, et al.
Plastic and Reconstructive Surgery|August 26, 2020
Psychometric Findings for the SCAR-Q Patient-Reported Outcome Measure Based on 731 Children and Adults with Surgical, Traumatic, and Burn Scars from Four CountriesNatalia I Ziolkowski, Andrea L Pusic, Joel S Fish, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trialGennaro Sardella, Simone Calcagno, Massimo Mancone, et al.
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
HIV Medicine|December 17, 2023
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effectsAlice Ranzani, Francesco Castelli, Antonio Di Biagio, et al.
Pageof 136

Showing results (1011-1020 of 1,352) with videos related to

Sort By:
Pageof 136
Cancer|December 24, 1997
A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumorsG Mariani, A Lasku, A Pau, et al.
Infection|May 20, 2015
Ageing with HIV: a multidisciplinary reviewA Calcagno, S Nozza, C Muss, et al.
Gut|March 9, 2007
HLA related genetic risk for coeliac diseaseMathieu Bourgey, Giuseppe Calcagno, Nadia Tinto, et al.
Anticancer Research|July 15, 2009
MYC insertions in diffuse-type gastric adenocarcinomaDanielle Queiroz Calcagno, Adriana Costa Guimarães, Mariana Ferreira Leal, et al.
Therapeutic Drug Monitoring|March 13, 2012
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical settingMarco Siccardi, Antonio DʼAvolio, Sonia Rodriguez-Novoa, et al.
The Laryngoscope|July 5, 2019
Incidence of inadequate perforators and salvage options for the anterior lateral thigh free flapWilliam W Thomas, Haley E Calcagno, James Azzi, et al.
Plastic and Reconstructive Surgery|August 26, 2020
Psychometric Findings for the SCAR-Q Patient-Reported Outcome Measure Based on 731 Children and Adults with Surgical, Traumatic, and Burn Scars from Four CountriesNatalia I Ziolkowski, Andrea L Pusic, Joel S Fish, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trialGennaro Sardella, Simone Calcagno, Massimo Mancone, et al.
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
HIV Medicine|December 17, 2023
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effectsAlice Ranzani, Francesco Castelli, Antonio Di Biagio, et al.
Pageof 136